Evidence map›Paper›PMID 29045464›Full record

ArticlePLoS pathogens2017

TIP60 represses telomerase expression by inhibiting Sp1 binding to the TERT promoter.

Deepa Rajagopalan, Amit Kumar Pandey, Magdalene Claire Xiuzhen, Kwok Kin Lee, Shainan Hora, Yanzhou Zhang, Boon Haow Chua, Hui Si Kwok, Shreshtha Sailesh Bhatia, Lih Wen Deng and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. TRRAP-mediated acetylation on Sp1 regulates adult neurogenesis.Computational and structural biotechnology journal · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Beyond HAT Adaptor: TRRAP Liaisons with Sp1-Mediated Transcription.International journal of molecular sciences · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Tip60: updates.Journal of applied genetics · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Deepa RajagopalanCancer Science Institute of Singapore, National University of Singapore, Singapore.ORCID http://orcid.org/0000-0002-3652-7176
Amit Kumar PandeyCancer Science Institute of Singapore, National University of Singapore, Singapore.
Magdalene Claire XiuzhenCancer Science Institute of Singapore, National University of Singapore, Singapore.
Kwok Kin LeeCancer Science Institute of Singapore, National University of Singapore, Singapore.
Shainan HoraCancer Science Institute of Singapore, National University of Singapore, Singapore.
Yanzhou ZhangCancer Science Institute of Singapore, National University of Singapore, Singapore.
Boon Haow ChuaCancer Science Institute of Singapore, National University of Singapore, Singapore.ORCID http://orcid.org/0000-0002-6234-7603
Hui Si KwokCancer Science Institute of Singapore, National University of Singapore, Singapore.
Shreshtha Sailesh BhatiaCancer Science Institute of Singapore, National University of Singapore, Singapore.ORCID http://orcid.org/0000-0002-3450-2266
Lih Wen DengDepartment of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Daniel G TenenCancer Science Institute of Singapore, National University of Singapore, Singapore.
Dennis KappeiCancer Science Institute of Singapore, National University of Singapore, Singapore.
Sudhakar JhaCancer Science Institute of Singapore, National University of Singapore, Singapore.ORCID http://orcid.org/0000-0002-5093-4843
National University of Singapore · SGHarvard University · US

Funding

TYROSINE KINASE ONCOGENESIS IN MYELOID LEUKEMIAP01CA066996 · NCI · DANA-FARBER CANCER INSTITUTE · PI SCOTT A ARMSTRONG · 1996 to 2026
$52.5M
Transcriptional and epigenetic heterogeneity of stem/progenitor cellsP01HL131477 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI David T Scadden · 2017 to 2026
$24.6M
Mechanisms of regulation by RNA in acute myeloid leukemiaR35CA197697 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TENEN, DANIEL G · 2015 to 2021
$7.1M
NCI NIH HHS P01 CA066996NCI NIH HHS R35 CA197697NHLBI NIH HHS P01 HL131477
6 · The paper itself

Abstract

HIV1-TAT interactive protein (TIP60) is a haploinsufficient tumor suppressor. However, the potential mechanisms endowing its tumor suppressor ability remain incompletely understood. It plays a vital role in virus-induced cancers where TIP60 down-regulates the expression of human papillomavirus (HPV) oncoprotein E6 which in turn destabilizes TIP60. This intrigued us to identify the role of TIP60, in the context of a viral infection, where it is targeted by oncoproteins. Through an array of molecular biology techniques such as Chromatin immunoprecipitation, expression analysis and mass spectrometry, we establish the hitherto unknown role of TIP60 in repressing the expression of the catalytic subunit of the human telomerase complex, TERT, a key driver for immortalization. TIP60 acetylates Sp1 at K639, thus inhibiting Sp1 binding to the TERT promoter. We identified that TIP60-mediated growth suppression of HPV-induced cervical cancer is mediated in part due to TERT repression through Sp1 acetylation. In summary, our study has identified a novel substrate for TIP60 catalytic activity and a unique repressive mechanism acting at the TERT promoter in virus-induced malignancies.

Indexed as

Gene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticResponse ElementsFemaleHeLa CellsHistone AcetyltransferasesHumansLysine Acetyltransferase 5Neoplasm ProteinsSp1 Transcription FactorTelomeraseUterine Cervical NeoplasmsHistone AcetyltransferasesKAT5 protein, humanLysine Acetyltransferase 5Neoplasm ProteinsSP1 protein, humanSp1 Transcription FactorTelomeraseTERT protein, human

Identifiers

PMID29045464
PMCPMC5662243
OpenAlexW2765788670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.